Researching Modifiable and Non-Modifiable Risk Factors Linked to Cognitive Resilience in Alzheimer’s Disease
What do we do?
Our lab focuses on clarifying how alterations in the brain and other biomolecules (such as cerebrospinal fluid β-amyloid) place some cognitively-normal individuals on a pernicious trajectory that culminates in Alzheimer’s dementia. In this context, we are particularly interested in discovering new knowledge concerning the modulation of the link between brain changes and cognitive decline by both modifiable (e.g., cognitively-stimulating activities, physical exercise) and non-modifiable (e.g., genetic vulnerability) factors. Overlaid on this research agenda are investigations of health accessibility, and how such accessibility exacerbates or ameliorates the impact of biomarkers on clinical phenotypes.
We use many techniques in our research, including but not limited to:
This is an accordion element with a series of buttons that open and close related content panels.
MRI and PET Imaging


Cerebrospinal Fluid Collection

Maximal Exercise Testing


Blood-based Biomarkers

Physical Activity Monitoring

Cognitive Testing

We are a part of the larger Wisconsin Alzheimer’s Disease Research Program, which includes both the Wisconsin Alzheimer’s Disease Research Center and the Wisconsin Alzheimer’s Institute.
Our offices are located on UW Madison’s campus within the UW Hospital and WARF. The majority of our research is conducted at the UW Hospital, the Waisman Center, the Wisconsin Institute for Medical Research, and the YMCA.
News Highlights

Gabriella Mamlouk Receives Fan Favorite Lightning Presentation Award at ADRD Research Day 2026.
Gabriella received Fan Favorite Lightning Presentation Awardee for delivering her presentation “Racial identity moderates the association between depression and AD-relevant plasma biomarkers in a multi-ethnic cohort” at the 2026 ADRD Research Day. Congratulations, Gabby!
April 16, 2026
Emma Nicolaysen Receives Best Graduate Student Poster Award at ADRD Research Day 2026.
Emma received Best Graduate Student Poster Awardee for presenting her poster “KLOTHO KL-VS heterozygosity attenuates the association between age-related neurodegeneration and subsequent decline in executive function in a cohort of cognitively unimpaired middle-aged and older …
April 16, 2026
Marissa Torres-Raby Accepted into Medical School
Marissa Torres-Raby was accepted into the University of Wisconsin – Madison Medical School (starting in August 2026)! Congratulations, Marissa – we are so very proud of you and are excited for you to continue your …
April 16, 2026
Ozioma Okonkwo to Serve as an Associate Editor for Alzheimer’s & Dementia: Translational Research and Clinical Interventions
Dr. Ozioma Okonkwo has been invited to serve as an Associate Editor for Alzheimer’s & Dementia: Translational Research and Clinical Interventions. Congratulations, Ozioma!
March 27, 2026- More News





